2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide

C168H141N21O7 — CID 159829946

IUPAC2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide
SMILESCC(=O)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CC1CCCCC1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CCCc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CCc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Cc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Nc1ncc(-c2ccccc2)nc1-c1ccccc1)c1ccccc1
InChIInChI=1S/C28H21N3O.C26H23N3O.C25H21N3O.C24H25N3O.C24H19N3O.C23H17N3O.C18H15N3O/c32-26(18-20-15-16-21-9-7-8-14-24(21)17-20)31-28-27(23-12-5-2-6-13-23)30-25(19-29-28)22-10-3-1-4-11-22;30-24(18-10-13-20-11-4-1-5-12-20)29-26-25(22-16-8-3-9-17-22)28-23(19-27-26)21-14-6-2-7-15-21;29-23(17-16-19-10-4-1-5-11-19)28-25-24(21-14-8-3-9-15-21)27-22(18-26-25)20-12-6-2-7-13-20;2*28-22(16-18-10-4-1-5-11-18)27-24-23(20-14-8-3-9-15-20)26-21(17-25-24)19-12-6-2-7-13-19;27-23(19-14-8-3-9-15-19)26-22-21(18-12-6-2-7-13-18)25-20(16-24-22)17-10-4-1-5-11-17;1-13(22)20-18-17(15-10-6-3-7-11-15)21-16(12-19-18)14-8-4-2-5-9-14/h1-17,19H,18H2,(H,29,31,32);1-9,11-12,14-17,19H,10,13,18H2,(H,27,29,30);1-15,18H,16-17H2,(H,26,28,29);2-3,6-9,12-15,17-18H,1,4-5,10-11,16H2,(H,25,27,28);1-15,17H,16H2,(H,25,27,28);1-16H,(H,24,26,27);2-12H,1H3,(H,19,20,22)
InChIKeyNNIJREYNBZHWTG-UHFFFAOYSA-N
MW2566.12 g/mol
LogP36.84
Rot. Bonds35

About 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide

2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide (PubChem CID 159829946) has the molecular formula C168H141N21O7 and a molecular weight of 2566.12 g/mol. Its IUPAC name is 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide.

Molecular Properties

Compound Name2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide
PubChem CID159829946
Molecular FormulaC168H141N21O7
Molecular Weight2566.12 g/mol
Exact Mass2564.13
IUPAC Name2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide
SMILESCC(=O)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CC1CCCCC1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CCCc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CCc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Cc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Nc1ncc(-c2ccccc2)nc1-c1ccccc1)c1ccccc1
InChIInChI=1S/C28H21N3O.C26H23N3O.C25H21N3O.C24H25N3O.C24H19N3O.C23H17N3O.C18H15N3O/c32-26(18-20-15-16-21-9-7-8-14-24(21)17-20)31-28-27(23-12-5-2-6-13-23)30-25(19-29-28)22-10-3-1-4-11-22;30-24(18-10-13-20-11-4-1-5-12-20)29-26-25(22-16-8-3-9-17-22)28-23(19-27-26)21-14-6-2-7-15-21;29-23(17-16-19-10-4-1-5-11-19)28-25-24(21-14-8-3-9-15-21)27-22(18-26-25)20-12-6-2-7-13-20;2*28-22(16-18-10-4-1-5-11-18)27-24-23(20-14-8-3-9-15-20)26-21(17-25-24)19-12-6-2-7-13-19;27-23(19-14-8-3-9-15-19)26-22-21(18-12-6-2-7-13-18)25-20(16-24-22)17-10-4-1-5-11-17;1-13(22)20-18-17(15-10-6-3-7-11-15)21-16(12-19-18)14-8-4-2-5-9-14/h1-17,19H,18H2,(H,29,31,32);1-9,11-12,14-17,19H,10,13,18H2,(H,27,29,30);1-15,18H,16-17H2,(H,26,28,29);2-3,6-9,12-15,17-18H,1,4-5,10-11,16H2,(H,25,27,28);1-15,17H,16H2,(H,25,27,28);1-16H,(H,24,26,27);2-12H,1H3,(H,19,20,22)
InChIKeyNNIJREYNBZHWTG-UHFFFAOYSA-N
XLogP36.84
TPSA384.16 Ų
H-Bond Donors7
H-Bond Acceptors21
Rotatable Bonds35
Heavy Atoms196
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002566.12
LogP ≤ 536.84
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1021

Analyze 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide
CID 159051784
N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide
CID 160783148
N-[3,5-bis(4-hydroxyphenyl)pyrazin-2-yl]-3-phenylpropanamide
CID 137101630
2-(3,4-dimethylphenyl)-N-(3,5-diphenylpyrazin-2-yl)acetamide
CID 143000963
N-[3-(cyclopentylmethyl)-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide
CID 136624996
N-[3-cyclohexyl-5-[4-(hydroxymethyl)phenyl]pyrazin-2-yl]-2-phenylacetamide
CID 123244301
N-(3-cyclohexyl-5-phenylpyrazin-2-yl)-2-(3,4-difluorophenyl)acetamide
CID 123435419
N-[8-(hydroxymethyl)-2-(4-hydroxyphenyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-2-naphthalen-2-ylacetamide;N-[8-(hydroxymethyl)-2-(4-hydroxyphenyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-2-phenylacetamide;N-[8-(hydroxymethyl)-2-(4-hydroxyphenyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-4-phenylbutanamide;N-[8-(hydroxymethyl)-2-(4-hydroxyphenyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-3-phenylpropanamide
CID 159043179
N-[3-(cyclohexylmethyl)-5-[4-(hydroxymethyl)phenyl]pyrazin-2-yl]-2-phenylacetamide
CID 123882448
N-[8-(hydroxymethyl)-2-(2-phenylethyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-2-naphthalen-2-ylacetamide;N-[8-(hydroxymethyl)-2-(2-phenylethyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-2-phenylacetamide;N-[8-(hydroxymethyl)-2-(2-phenylethyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-4-phenylbutanamide;N-[8-(hydroxymethyl)-2-(2-phenylethyl)-5,6-dihydrobenzo[f]quinoxalin-3-yl]-3-phenylpropanamide
CID 157118513
2-(4-chlorophenyl)-N-[3-(4-hydroxyphenyl)-5-phenylpyrazin-2-yl]acetamide
CID 136624974
N-[3-benzyl-5-(3,4-dihydroxyphenyl)pyrazin-2-yl]-2-cyclohexylacetamide
CID 136625269

Frequently Asked Questions

What is the IUPAC name of 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide?
The IUPAC name of 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide (CID 159829946) is 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide.
What is the SMILES notation for 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide?
The canonical SMILES for 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide is CC(=O)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CC1CCCCC1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CCCc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(CCc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Cc1ccccc1)Nc1ncc(-c2ccccc2)nc1-c1ccccc1.O=C(Nc1ncc(-c2ccccc2)nc1-c1ccccc1)c1ccccc1.
What is the InChIKey of 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide?
The InChIKey is NNIJREYNBZHWTG-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H21N3O.C26H23N3O.C25H21N3O.C24H25N3O.C24H19N3O.C23H17N3O.C18H15N3O/c32-26(18-20-15-16-21-9-7-8-14-24(21)17-20)31-28-27(23-12-5-2-6-13-23)30-25(19-29-28)22-10-3-1-4-11-22;30-24(18-10-13-20-11-4-1-5-12-20)29-26-25(22-16-8-3-9-17-22)28-23(19-27-26)21-14-6-2-7-15-21;29-23(17-16-19-10-4-1-5-11-19)28-25-24(21-14-8-3-9-15-21)27-22(18-26-25)20-12-6-2-7-13-20;2*28-22(16-18-10-4-1-5-11-18)27-24-23(20-14-8-3-9-15-20)26-21(17-25-24)19-12-6-2-7-13-19;27-23(19-14-8-3-9-15-19)26-22-21(18-12-6-2-7-13-18)25-20(16-24-22)17-10-4-1-5-11-17;1-13(22)20-18-17(15-10-6-3-7-11-15)21-16(12-19-18)14-8-4-2-5-9-14/h1-17,19H,18H2,(H,29,31,32);1-9,11-12,14-17,19H,10,13,18H2,(H,27,29,30);1-15,18H,16-17H2,(H,26,28,29);2-3,6-9,12-15,17-18H,1,4-5,10-11,16H2,(H,25,27,28);1-15,17H,16H2,(H,25,27,28);1-16H,(H,24,26,27);2-12H,1H3,(H,19,20,22).
What are the key properties of 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide?
2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide has a molecular weight of 2566.12 g/mol, XLogP of 36.84, 35 rotatable bonds, 7 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide is sourced from PubChem (CID 159829946), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).